学术探索
学术期刊
新闻热点
数据分析
智能评审

Atypical antipsyshotic drugs in treatment-refractory schizophrenia

被引：11
作者：
Bradford, DW
Chakos, MH
Sheitman, BB
Lieberman, JA
机构：
[1] Univ N Carolina, Sch Med, Dept Psychiat, Neurosci Hosp 7025, Chapel Hill, NC 27599 USA
[2] Zeneca Inc, Wilmington, DE USA
[3] Pfizer Inc, New York, NY 10017 USA
[4] Eli Lilly & Co, Indianapolis, IN 46285 USA
[5] Pharmacia & Upjohn Inc, Kalamazoo, MI 49001 USA
来源：
PSYCHIATRIC ANNALS | 1998年 / 28卷 / 11期
关键词：
D O I：
10.3928/0048-5713-19981101-06
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
There is great interest in determining whether the atypical antipsychotic drugs have enhanced efficacy in patients with treatment-refractory illness. This article reviews several studies on this topic.
引用
收藏
页码：618 / +
页数：10
相关论文
共 57 条
  • [1] The effects of clozapine on symptom clusters in treatment-refractory patients
    Abraham, G
    Nair, C
    Tracy, JI
    Simpson, GM
    Josiassen, RC
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1997, 17 (01) : 49 - 53
  • [2] Ten years' experience with clozapine in treatment-resistant schizophrenic patients:: factors indicating the therapeutic response
    Alvarez, E
    Barón, F
    Perez-Blanco, J
    Soriano, DPJ
    Masip, C
    Perez-Solá, V
    [J]. EUROPEAN PSYCHIATRY, 1997, 12 : 343S - 346S
  • [3] Andreasen N, 1984, SCALE ASSESSMENT POS
  • [4] [Anonymous], 1984, SCALE ASSESSMENT POS
  • [5] Beck NC, 1997, J AM ACAD PSYCHIATRY, V25, P461
  • [6] Risperidone versus clozapine in treatment-resistant chronic schizophrenia: A randomized double-blind study
    Bondolfi, G
    Dufour, H
    Patris, M
    May, JP
    Billeter, U
    Eap, CB
    Baumann, P
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 1998, 155 (04) : 499 - 504
  • [7] DEFINING TREATMENT REFRACTORINESS IN SCHIZOPHRENIA
    BRENNER, HD
    DENCKER, SJ
    GOLDSTEIN, MJ
    HUBBARD, JW
    KEEGAN, DL
    KRUGER, G
    KULHANEK, F
    LIBERMAN, RP
    MALM, U
    MIDHA, KK
    [J]. SCHIZOPHRENIA BULLETIN, 1990, 16 (04) : 551 - 561
  • [8] Effects of clozapine on plasma catecholamines and relation to treatment response in schizophrenia: A within-subject comparison with haloperidol
    Brown, AS
    Gewirtz, G
    HarkavyFriedman, J
    Cooper, T
    Brebion, G
    AMador, XF
    Malaspina, D
    Gorman, JM
    [J]. NEUROPSYCHOPHARMACOLOGY, 1997, 17 (05) : 317 - 325
  • [9] Buchanan RW, 1998, AM J PSYCHIAT, V155, P751
  • [10] BUNNEY WE, 1963, ARCH GEN PSYCHIAT, V9, P280
123456